RE:RE:Useful Actionable information from Hulot............Bahahahahahahaha RBC analysts put this at $1.00 price target and I think they are being optimistic. Scotia puts it at 50 cents.
You must have patience to see this thing tank every day and still be here pumping it.
As for your balls....
MrHulot wrote: You want useful information RADish. Here it is:
CXR is a unique opportunity. If you have enough patience and balls, this investment has the potential for huge gains. I have already explained the reasons for the downturn in earlier posts. Bad timing. Bad Luck. Then the Company when into shock and a tailspin. Like a chicken without its head so to speak. You’d know that right, Lattice. Take a look at recent history: With almost the same fundamentals CXR was $65 only 15 months ago. Let's say the company conservatively makes $3 per share as analysts estimate in 2017. 50/3=16.7 PE that is lower than the average PE in the Pharma industry. This is crazy for this stock. Let's assume the market is forward looking, basing a decision on analyst assessments. If leading analysts put 2017 at EPS $3, then why are market estimates giving a share price below $3? Huge opportunity. Any chance for Bankruptcy? Sure, but not earlier than four years. If Bankruptcy is not on the horizon than I conclude THIS IS THE CHEAPEST PHARMA STOCK ON THE PLANET.